封面
市场调查报告书
商品编码
1435246

几丁聚醣-全球市场占有率分析、产业趋势与统计、成长预测(2024-2029)

Global Chitosan - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2024年全球几丁聚醣市场规模为20.9亿美元,预估至2029年将达36.7亿美元,预测期间(2024-2029年)复合年增长率为11.93%。

全球壳聚醣市场

世界各地的研究人员对将几丁聚醣作为预防和治疗感染疾病的潜在药物在製药和生物医学领域的应用表现出了兴趣。 2019 年 12 月,中国成为 SARS-CoV-2 疫情的震央,此后疫情在国际上蔓延。 2020 年,世界卫生组织 (WHO) 宣布 COVID-19 为全球卫生紧急事件。应对新型冠状病毒感染疾病(COVID-19) 等病毒性疾病爆发的影响需要世界各地研究人员的研究和开发工作。因此,新型COVID-19的爆发可能会对市场成长产生积极影响,因为几丁聚醣聚合物作为病毒抑制剂的应用将在不久的将来创造显着的成长机会。

此外,几丁聚醣等生物聚合物具有固有的抗病毒特性。基于奈米结构药物传递系统(NDDS)的碳水化合物粘合剂,例如硫酸化聚合物,也会改变病毒的进入过程,阻断病毒的阳离子表面受体并与宿主细胞表面的硫酸乙酰肝素蛋白聚醣相互作用,从而可以避免这种影响。然而,到目前为止,还没有 NDDS 被用作治疗方法COVID-19 疾病的报告。它可能在不久的将来成为治疗 COVID-19 的新方法。

其他推动市场成长的因素包括生物医学、化妆品、食品和饮料行业产品应用的增加、全球水处理活动的增加以及已开发国家医疗保健/医疗行业的重大进步。

由几丁聚醣组成的系统利用几丁聚醣的特性来达到优异的治疗效果。例如,几丁聚醣的黏合特性可用于非侵入性黏膜疫苗载体。因此,由几丁聚醣组成的系统在治疗感染疾病方面具有巨大的潜力。

几丁聚醣是一种天然多醣,具有生物分解性、无毒、生物相容性、止血和黏合以及渗透增强特性等特性。此外,它还具有抗菌特性。

据美国国家生物技术资讯中心(NCBI)称,去乙酰几丁聚醣是过滤和水处理中必不可少的添加剂,可去除 99% 的浊度。此外,几丁聚醣是一种从渔业废弃物中提取的现成产品,在其他行业中具有多种用途,例如製药行业中的伤口护理材料,用作天然调味剂,并用于食品行业。水分控制,增加了对这些聚合物的需求,并进一步提振了整个市场。

此外,严格的政府法规迫使製造商减少塑胶袋,导致对生物分解性塑胶的需求增加,其中甲壳素被广泛使用。这增加了几丁聚醣的采用,进一步推动预测期内的市场成长。

几丁聚醣市场趋势

根据应用,水处理预计在预测期内呈现健康成长速度

由于工业、商业和市政水处理厂对几丁聚醣的需求不断增加,未来水处理可望健康成长。由于其能够去除水中的农药、表面活性剂和酚类等优点,它在水处理厂中受到高度青睐。由于几丁聚醣无毒、不过敏和生物分解性的特性,其作为水质净化剂的需求不断增加,也将推动该产业的成长。

最近有报告指出,水和污水中存在严重急性呼吸症候群冠状病毒 2 (SARS-CoV-2)。 COVID-19患者的粪便和口罩被认为是冠状病毒传播到水和污水的主要途径。

例如,Hai Nguyen Tran 等人发表在《环境研究杂誌 2021》上的一篇研究论文证实,在进水污水中检测到了 SARS-CoV-2 RNA。然而,已证实进水中存在 SARS-CoV-2。因此,未来我们将检视不同操作条件下SARS-CoV-2在水和污水中的生存状况,以及将受COVID-19污染的水传播给人类是否是一个新出现的问题,值得研究重点。因此,预计在不久的将来,使用几丁聚醣进行水处理将有助于预防新型冠状病毒感染疾病(COVID-19)等病毒性疾病。

此外,几丁聚醣具有更快的沉积速率、更高的COD(有机物)、金属离子和SS(悬浮固体)去除效率等特性,是自来水处理的优异凝聚剂。此外,随着世界各国更加重视污水处理以尽量减少污染,未来几年对几丁聚醣的需求可能会持续增加。

由于地下水位下降和城市人口快速成长,亚太国家正面临可用淡水的严重短缺。这导致政府和私人公司(主要是印度、中国和马来西亚)对水处理进行投资。

以印度为例,2012年至2017年,印度规划委员会累计约265亿美元,为印度都市区所有人提供安全用水。污水处理、污水处理、固体、液体和化学废弃物、水技术、环境服务、海水淡化公司、咨询、工程等是印度应对水挑战所需的一些服务。

此外,2019年,印度政府与巴巴核能研究中心(BARC)合作,计画在村庄建立水质净化厂。政府的目标是到2024年为所有人提供干净的饮用水。因此,预计上述因素将在预测期内推动该细分市场的成长。

预计北美在预测期内将占据重要市场份额

由于主要参与者的存在以及美国对水处理的认识不断提高以及对化妆品的需求不断增长,预计北美将在全球几丁聚醣市场中占据重要的市场占有率。此外,不断增长的医疗保健支出和成熟的医疗保健基础设施也显着推动了整个区域市场的成长。

由于在疾病管理中基于几丁聚醣的治疗和防护设备开发的研究和开发的增加,COVID-19感染疾病大流行对几丁聚醣市场产生了积极的反应。 2021年,正在进行临床研究,调查含有几丁聚醣奈米粒子的过滤元件的新型口罩的防护效果,已被证明对市场产生正面影响。

该地区日益严重的肥胖和超重问题,以及人们健康意识的提高,是几丁聚醣市场的关键机会。例如,根据加拿大健康资讯研究所的数据,肥胖是加拿大主要的国民健康问题之一,五分之一的加拿大成年人患有肥胖症。根据2017年加拿大肥胖网络报告,700万加拿大人患有肥胖症。

由于日本、中国、印度和韩国终端用户产业的快速发展,预计亚太地区在预测期内也将出现健康成长。对生物基产品的需求不断增长以及政府的支持和倡议预计也将推动几丁聚醣市场的发展。

推动亚太地区几丁聚醣需求的主要因素之一是从渔业废弃物中获得的原料的现成可用。例如,根据联合国粮食及农业组织统计,2019年上半年,中国进口虾28.59万吨,主要来自厄瓜多尔、印度和沙乌地阿拉伯,比中国进口10万吨增加186% 。做过。因此,由于上述因素,市场可能会成长。

几丁聚醣产业概况

几丁聚醣市场分散,竞争激烈,由几个主要企业组成。从市场占有率来看,目前几家大公司占据市场主导地位。目前主导市场的公司包括Panvo Organics Pvt Ltd、GTC Bio Corporation、Dupont Corporation、KitoZyme SA、KIMICA Corporation、Dainichiseika Color & Chemicals Mfg、Heppe Medical Chitosan GmbH、Meron Biopolymers、青岛云洲、Biophrame Technologies等。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 市场概况
  • 市场驱动因素
    • 活性化水处理活动
    • 扩大产品在生物医学、化妆品、食品和饮料产业的应用
    • 医疗保健/医疗产业的强劲进步
  • 市场限制因素
    • 法律规范
  • 波特五力分析
    • 新进入者的威胁
    • 买家/消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度

第五章市场区隔

  • 按原料分
    • 虾(虾)
    • 虾(虾)
    • 螃蟹
    • 其他原料
  • 按用途
    • 水处理
    • 化妆品
    • 製药/生物医学
    • 食品和饮料
    • 其他用途
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区
    • 中东/非洲
      • GCC
      • 南非
      • 其他中东和非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区

第六章 竞争形势

  • 公司简介
    • Panvo Organics Pvt Ltd
    • GTC Bio Corporation
    • Dupont Corporation
    • KitoZyme SA
    • KIMICA Corporation
    • Dainichiseika Color & Chemicals Mfg Co. Ltd
    • Heppe Medical Chitosan GmbH
    • Meron Biopolymers
    • Qingdao Yunzhou
    • Biophrame Technologies
    • ChitoTech
    • Marshal Marine
    • BIO21 Co. Ltd
    • Austanz Chitin Pty Ltd
    • KiOmed Pharma

第七章 市场机会及未来趋势

简介目录
Product Code: 68902

The Global Chitosan Market size is estimated at USD 2.09 billion in 2024, and is expected to reach USD 3.67 billion by 2029, growing at a CAGR of 11.93% during the forecast period (2024-2029).

Global Chitosan - Market

Globally, researchers are showing interest in the use of chitosan in the pharmaceutical and biomedical fields as a potential agent for the prevention and treatment of infectious diseases. In December 2019, China became the epicenter of the SARS-CoV-2 outbreak, which has since spread internationally. In 2020, the World Health Organization (WHO) declared COVID-19 to be a global health emergency. Countering the impacts of viral disease outbreaks such as COVID-19 required R&D activities by researchers across the globe. Thus, the COVID-19 outbreak is likely to show a positive impact on the market growth as the application of chitosan polymers as viral inhibitors would generate key growth opportunities in the near future.

Furthermore, biopolymers such as chitosan have intrinsic antiviral properties. Nanostructured drug-delivery systems (NDDS)-based carbohydrate-binding agents, such as the sulfated polymers, can also change the virus entry process, blocking the viral cationic surface receptors and avoiding its interaction with heparan sulfate proteoglycan on the host cell surface. However, there are no reports of NDDS as COVID-19 treatment so far. It can be a new approach for COVID-19 treatment in the near future.

The other factors driving the market growth include growing product applications in biomedical, cosmetics, and food and beverage industries, rising water treatment activities worldwide, and strong advancements in the healthcare/medical industry in developed countries.

Chitosan composed systems utilize the characteristics of chitosan to achieve great therapeutic effects. For instance, the adhesiveness of chitosan can be used for non-invasive mucosal vaccine vectors. Therefore, chitosan-composed systems have great potential in the therapy of infectious diseases.

Chitosan is a natural polysaccharide that exhibits properties such as biodegradability, non-toxicity, biocompatibility, hemostatic and bio-adhesiveness, and penetration-enhancing properties. Moreover, it has anti-microbial properties.

As per National Center for Biotechnology Information (NCBI), deacetylated chitosan is a vital additive in filtration and water treatment, which eliminates 99% of turbidity. Moreover, chitosan is an easily available product extracted from a waste product in the fishery industry with several uses in other industries such as wound care material in pharmaceutical industries, acts as a natural flavor, and used to control moisture in food industries leading to the high demand for these polymer and further boost the overall market.

Furthermore, stringent government regulations are forcing manufactures to reduce plastic bags, resulting in the growing demand for biodegradable plastic where chitin is being widely used. This led to the increasing adoption of chitosan and further drive the market growth over the forecast period.

Chitosan Market Trends

Under Application, Water Treatment is Expected to Witness a Healthy Growth Rate Over the Forecast Period

Water treatment is expected to witness healthy growth in the future, attributing to the growing demand for chitosan in industries, commercial, and municipal water treatment plants. Several advantages, such as the ability to remove pesticides, surfactants, and phenol from water, make it highly preferable in water treatment plants. Increasing demand for chitosan as a water cleaner because of its non-toxic, non-allergic biodegradable nature will also be leading to propel the segment growth.

The presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in water and wastewater has recently been reported. The stools and masks of COVID-19 patients were considered as the primary route of coronavirus transmission into water and wastewater.

For instance, according to a research article by Hai Nguyen Tran et al. published in the Environmental Research Journal 2021, the study confirmed that SARS-CoV-2 RNA was detected in inflow wastewater. Although, the existence of SARS-CoV-2 in water influents has been confirmed. Therefore, in the future, studies should focus on the survival of SARS-CoV-2 in water and wastewater under different operational conditions and whether the transmission from COVID-19-contaminated water to humans is an emerging concern. Thus, the use of chitosan for water treatment in the near future is expected to encourage the prevention of viral diseases like COVID-19.

Furthermore, chitosan is a good flocculant for tap water treatment due to properties such as faster deposition rate and higher removal efficiency for COD (organic matter), metal ions, and SS (suspended solids). Moreover, as countries around the globe emphasize wastewater treatment to minimize pollution, chitosan's demand is likely to continue increasing in the coming years.

Depleting groundwater levels and the rapidly growing urban population in the Asia-Pacific countries have resulted in the acute scarcity of usable freshwater. This has led to investments by governments and private players in water treatments, mainly in India, China, and Malaysia.

For instance, in India, during 2012-2017, the Indian planning commission had budgeted around USD 26.5 billion to provide safe water to all urban and rural Indians. Treatment of sewage, wastewater treatment, solid, liquid, and chemical waste, water technology, environmental services, desalination companies, consulting, and engineering are some services that India will require to tackle the water problem.

In addition, in 2019, the Government of India, with the Bhabha Atomic Research Centre (BARC), planned to install water filtration plants in villages. The government targets to provide clean drinking water to everyone by 2024. Thus, owing to the above-mentioned factors, it is expected to drive the segment's growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant market share in the Global Chitosan Market, due to increasing awareness regarding water treatment and the growing demand for cosmetics in the United States, along with the presence of major players. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

The COVID-19 pandemic has shown a positive response toward the Chitosan Market as chitosan-based research and development has been increasing in the development of therapeutics or protective equipment in the management of the disease. In 2021, clinical studies are being conducted to investigate the protective effect of a new type of respirator with a filter element containing chitosan nanoparticles, which show a positive impact on the market.

Increasing obesity and overweight issues in the region and rising health awareness among people act as significant opportunities for the chitosan market. For instance, obesity is one of the major population health issues in Canada, affecting one in five Canadian adults as per the Canadian Institute for Health Information. Seven million Canadians were living with obesity, according to a 2017 Canadian Obesity Network report.

Asia-Pacific is also expected to grow at a healthy growth in the forecast period due to the rapid development of end-user industries in Japan, China, India, and South Korea. The increasing demand for biobased products, coupled with a supportive government, and initiatives would also boost the chitosan market.

One of the key factors driving the chitosan demand in the Asia-Pacific region is the easy availability of its raw material, obtained as a waste product from the fishery industry. For instance, according to the Food and Agriculture Organization of the United Nations, during the first half of 2019, China imported 285,900 tons of shrimp, mainly from Ecuador, India, and Saudi Arabia, which was 186% more compared to 100,000 tons imported in 2018. Thus, owing to the above-mentioned factors, the market is likely to grow.

Chitosan Industry Overview

The Chitosan Market is fragmented, competitive, and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market include Panvo Organics Pvt Ltd, GTC Bio Corporation, Dupont Corporation, KitoZyme SA, KIMICA Corporation, Dainichiseika Color & Chemicals Mfg Co. Ltd, Heppe Medical Chitosan GmbH, Meron Biopolymers, Qingdao Yunzhou, and Biophrame Technologies.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Water Treatment Activities
    • 4.2.2 Growing Product Application in the Biomedical, Cosmetics, and Food and Beverage Industries
    • 4.2.3 Strong Advancements in the Healthcare/Medical Industry
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Framework
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Source
    • 5.1.1 Shrimps
    • 5.1.2 Prawns
    • 5.1.3 Crabs
    • 5.1.4 Other Sources
  • 5.2 By Application
    • 5.2.1 Water treatment
    • 5.2.2 Cosmetics
    • 5.2.3 Pharmaceutical and Biomedical
    • 5.2.4 Food and Beverage
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Panvo Organics Pvt Ltd
    • 6.1.2 GTC Bio Corporation
    • 6.1.3 Dupont Corporation
    • 6.1.4 KitoZyme SA
    • 6.1.5 KIMICA Corporation
    • 6.1.6 Dainichiseika Color & Chemicals Mfg Co. Ltd
    • 6.1.7 Heppe Medical Chitosan GmbH
    • 6.1.8 Meron Biopolymers
    • 6.1.9 Qingdao Yunzhou
    • 6.1.10 Biophrame Technologies
    • 6.1.11 ChitoTech
    • 6.1.12 Marshal Marine
    • 6.1.13 BIO21 Co. Ltd
    • 6.1.14 Austanz Chitin Pty Ltd
    • 6.1.15 KiOmed Pharma

7 MARKET OPPORTUNITIES AND FUTURE TRENDS